Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

NCT01984138 is registered in ClinicalTrials.gov with Polly A. Niravath, MD as lead sponsor.

NCT NCT01984138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01984138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Lead sponsor
Polly A. Niravath, MD
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 30, 2013
Completion date
June 30, 2026
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, estrogen receptor positive breast cancer